跳至主要内容
临床试验/NCT05086510
NCT05086510已完成不适用

Ablation Targets of Scar-related Ventricular Tachycardia Identified by Dynamic Functional Substrate Mapping

Ain Shams University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年10月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Number of Participants With Recurrence of Ventricular Tachycardia

研究概览

简要总结

This study aims at comparing the recurrence rates of ventricular tachycardia ablated after being mapped by 2 different techniques.

详细描述

The study participants are patients presented with recurrent ventricular tachycardia.

They will be divided into 2 groups in terms of mapping. The first group will use mapping during sinus rhythm to identify late potentials that may be incriminated in the tachycardia circuit.

The other group will undergo mapping during right ventricular extrastimulus pacing to unmask hidden potentials. The identified potentials will be ablated in both groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • • Patients with structural heart disease; previous myocardial infarction, left ventricular dilatation/systolic dysfunction, or normal left ventricular diameters/ systolic function with evidence of ventricular scar on contrast enhanced-cardiac magnetic resonance or electroanatomic map.
  • Sustained monomorphic ventricular tachycardia documented by 12-lead ECG or implantable cardioverter defibrillator (electrograms resistant to antiarrhythmic drug treatment or requiring implantable cardioverter defibrillator therapies.

排除标准

  • • Patients with ventricular arrhythmias attributed to reversible causes.

结局指标

主要结局

Number of Participants With Recurrence of Ventricular Tachycardia

时间窗: 12 months

Recurrence of ventricular tachycardia implies receiving at least one appropriate implantable cardioverter defibrillator therapy or hospital admission due to symptomatic ventricular tachycardia.

次要结局

  • Number of Participants Who Die From Any Cause (All-cause Mortality)(12 months)
  • Number of Participants Who Experience Cardiac Death(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohammad Gamal

Principal investigator

Ain Shams University

研究点 (1)

Loading locations...

相似试验